Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

jan_rehwinkel

Jan Rehwinkel, a Group leader in HIU,  has recently been awarded a Lister Institute Research Prize Fellowship to study “Z-RNA and Z-DNA: Novel Inducers of Antiviral Immunity”.  Jan says “In addition to the well-known B- and A-form, double-stranded DNA and RNA can also adopt the so-called Z-conformation. Z-DNA and Z-RNA are characterised by a left-handed double helix, the absence of major grooves and a zig-zag arrangement of the phosphodiester backbone (hence the name, Z-DNA/RNA). Physiological functions of Z-DNA and Z-RNA are incompletely understood. A clue to their potential biological roles is the observation that Z-alpha and Z-beta domains, which specifically bind to Z-DNA and Z-RNA, are found in four proteins that are all involved in innate antiviral immunity. This suggests an important role of Z-DNA and/or Z-RNA in innate antiviral immune responses.  We hypothesize that nucleic acids in Z-conformation are generated specifically in virus-infected cells and are a novel pathogen-associated molecular pattern (PAMP) detected by proteins containing Z-alpha and Z-beta domains. This award will allow us to test this idea for ZBP1 (Z-DNA binding protein 1).”